Psychiatric medications are no panacea. Recent studies have raised questions, for instance, about whether antidepressants are really any better than placebo pills. While I still believe that ...

Please provide your email address to receive an email when new articles are posted on . Long-acting injectable antipsychotics have been shown to prevent symptom relapse while addressing patient ...

File photo: Dr. Jeanie Tse, chief medical officer at the Institute for Community Living, administers antipsychotic medication to a patient living with schizophrenia in her home, Wednesday, May 6, 2020 ...

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia Long-acting injectable (LAI) antipsychotics may improve medication adherence and reduce relapse in patients with schizophrenia.

Antipsychotic injections upon hospital discharge were associated with a 75 percent reduction in 30-day rehospitalizations when compared with oral antipsychotics, according to a Rutgers Health study.

"Real-world" use of clozapine (multiple brands) and long-acting injectable antipsychotics is associated with the lowest risk for rehospitalization and treatment failure in newly diagnosed and ...

The authors concluded that “given that low compliance is a frequent cause of relapse in the early course of schizophrenia, more active consideration of LAI drugs should be encouraged, and patients ...